Want to join the conversation?
Pharmaceutical company $AKRX said it received a notice from the Nasdaq Listing Qualifications Staff stating non-compliance with Nasdaq Listing Rule 5250(c)(1) because the company did not file its Form 10-K for the year ended Dec. 31, 2015 with the SEC by Feb. 29, 2016. $AKRX aims to file the necessary periodic reports by the May 9, 2016 extension.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.